SinoVeda and JSL R&D Health Innovations Sign Business Development Agreement for Brazil

October 13, 2015

EDMONTON and RIO DE JANEIRO (October 13, 2015): SinoVeda Canada Inc. and JSL R&D Health Innovations announce the signing of a business development agreement for Brazil. JSL will be responsible for the promotion of SinoVeda’s products and services to Brazilian companies. Dr. Jaderson Lima, MSc. M.D., the founder and chief consulting officer of JSL, is […]

Biotechnology in Hong Kong: Volume II Publication

August 17, 2015

SinoVeda Canada Inc. is pleased to announce the forthcoming publication of Biotechnology in Hong Kong: Volume II, which includes a chapter written by company president Dr. Yun Tam, “Transforming Traditional Chinese Medicine to Mainstream Pharmaceuticals.” This chapter describes SinoVeda’s patented Pharmaceutical Platform Technology (PPT)®, the science supporting its efficacy, and its possible commercial applications.

SinoVeda and Exzell Pharma Sign Commercialization Agreement for Effecti-Cal®

August 12, 2015

EDMONTON and TORONTO (August 12, 2015): SinoVeda Canada Inc. and Exzell Pharma Inc. today announced the signing of an exclusive license agreement to commercialize Effecti-Cal® in Canada, the U.S., Australia and New Zealand. The agreement includes upfront and milestone payments, as well as royalties on sales. The specific terms of the transaction were not disclosed. […]